Stable composition of cholesterol-reducing agents, antihypertensives and platelet-antiaggregating agents.
WO2012087090A1
Stable composition of cholesterol-reducing agents, antihypertensives and platelet-antiaggregating agents
WO2011056056A2
Anti-cytokine vhnar domains
MX2008011303A
Analytical device for pregnancy or ovulation tests and method for using the same.
KR20110042165A
A new metformin glycinate salt for blood glucose control
MXPA06003717A
Ophtalmic compositions proteins for inhibiting cytokins involved in immunologic inflamatory processes.
MXPA06000760A
Stable pharmaceutical composition containing carisoprodol and meloxicam.
MXPA05009633A
Stable pharmaceutical composition comprising immediate-release glimepiride and delayed-release metformin.
EP1651266A1
Administration of anti-tnf-alpha f(ab')2 antibody fragments
EP1482919A1
Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
MXPA00012407A
Novel substituted pyrrole compound.
CA2417353A1
Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-one, and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
WO0105354A2
Improved process for the preparation of benzenesulfonylureas as oral hypoglycemic agents of the second generation
